Selenium is an essential component of the human diet because it is incorporated into at least 25 human proteins whose functions are required for key elements in human health, including the regulation of inflammation, male fertility and cellular antioxidant activity. Although it is known that selenium is incorporated in the form of the "21st" amino acid, selenocysteine (Sec), the mechanism by which Sec incorporation occurs is unknown. To date, four factors are known to be required for the conversion of a UGA stop codon into one encoding Sec in eukaryotes: a cis-sequence in the selenoprotein mRNA termed a Sec insertion sequence (SECIS) element, the Sec-specific elongation factor (eEFSec) that carries the Sec-tRNASec, and a SECIS binding protein, SBP2. While these four factors are essential for Sec incorporation, their mechanism of action has not been determined. The overall goal of this work is to decipher the mechanism by which Sec incorporation is achieved with a focus on elongation factor specificity as well as the identification of novel factors that promote efficient and processive Sec incorporation. Our guiding hypothesis is that an SBP2/SECIS complex provides a signal to the eEFSec ternary complex (eEFSec/Sec-tRNASec/GTP) that allows it to bind the ribosomal A site, and that this mechanism is modified by as-yet unidentified factors to yield an efficient and processive reaction. To test this hypothesis, three specific aims are proposed. First, we will identify the determinants for specificity in the Sec-specific elongation factor, eEFSec. Since eEFSec functions analogously and in parallel with canonical translation elongation, we propose to analyze eEFSec function in the context of the known functions of the canonical homolog eEF1A, including the development of a novel eEFSec assay system and a determination of the role GTP hydrolysis in Sec incorporation. Second, we will determine the mechanism of eEFSec function and regulation. The recruitment of eEFSec by the SBP2/SECIS complex is likely an integral part of the Sec incorporation reaction, thus we propose to elucidate the mechanism, conformational consequences and amino acid sequences required for SBP2/ SECIS/eEFSec complex formation. Finally, we propose the identification and characterization of the novel factors required for processive and efficient Sec incorporation. SBP2 and eEFSec may be sufficient for basal Sec incorporation, but these two factors are unable to support efficient Sec incorporation in vitro or in transfected cells. Since both efficiency and processivity are essential features of selenoprotein production in vivo, we propose to identify the factors and cis-elements required, thus expanding the field to include specific regulators of the basal Sec incorporation machinery. Together these three aims represent an integrated molecular approach to identifying the mechanism of Sec incorporation in order to fulfill the long term goal of enhancing selenoprotein function in vivo.

Public Health Relevance

This proposal is designed to provide essential information regarding the processes required for the utilization of dietary selenium. Selenium is incorporated into proteins as selenocysteine by means of a unique modification of standard protein synthesis. The completion of this project will reveal the molecular mechanism involved in Sec incorporation so that the system may be used as a target for regulating selenoprotein expression so as to maximize the beneficial properties of this group of antioxidative enzymes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
7R01GM077073-08
Application #
8720908
Study Section
Integrative Nutrition and Metabolic Processes Study Section (INMP)
Program Officer
Barski, Oleg
Project Start
2006-01-06
Project End
2015-03-31
Budget Start
2013-07-01
Budget End
2014-03-31
Support Year
8
Fiscal Year
2013
Total Cost
$266,419
Indirect Cost
$94,619
Name
Rbhs-Robert Wood Johnson Medical School
Department
Biochemistry
Type
Schools of Medicine
DUNS #
078795875
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
French, Rachel L; Gupta, Nirupama; Copeland, Paul R et al. (2014) Structural asymmetry of the terminal catalytic complex in selenocysteine synthesis. J Biol Chem 289:28783-94
Shetty, Sumangala P; Shah, Ravi; Copeland, Paul R (2014) Regulation of selenocysteine incorporation into the selenium transport protein, selenoprotein P. J Biol Chem 289:25317-26
Gupta, Nirupama; DeMong, Louise W; Banda, Sowmya et al. (2013) Reconstitution of selenocysteine incorporation reveals intrinsic regulation by SECIS elements. J Mol Biol 425:2415-22
Caban, Kelvin; Copeland, Paul R (2012) Selenocysteine insertion sequence (SECIS)-binding protein 2 alters conformational dynamics of residues involved in tRNA accommodation in 80 S ribosomes. J Biol Chem 287:10664-73
Esposito, Anthony M; Mateyak, Maria; He, Dongming et al. (2010) Eukaryotic polyribosome profile analysis. J Vis Exp :
Donovan, Jesse; Copeland, Paul R (2010) The efficiency of selenocysteine incorporation is regulated by translation initiation factors. J Mol Biol 400:659-64
Donovan, Jesse; Copeland, Paul R (2010) Threading the needle: getting selenocysteine into proteins. Antioxid Redox Signal 12:881-92
Donovan, Jesse; Copeland, Paul R (2009) Evolutionary history of selenocysteine incorporation from the perspective of SECIS binding proteins. BMC Evol Biol 9:229
Donovan, Jesse; Caban, Kelvin; Ranaweera, Ruchira et al. (2008) A novel protein domain induces high affinity selenocysteine insertion sequence binding and elongation factor recruitment. J Biol Chem 283:35129-39